Regen Biopharma Declares Series A Preferred Stock Dividend

The latest announcement is out from Regen Biopharma ( (RGBP) ).

On January 19, 2026, Regen Biopharma, Inc.’s board of directors declared a stock dividend for all shareholders of record as of February 3, 2026, to be paid on or about February 9, 2026, in the form of the company’s authorized but unissued Series A Preferred Stock. The dividend will grant one share of Series A Preferred Stock for every share of Regen’s common stock and each existing series of preferred stock (Series A, Series AA, Series M, and Series NC) held on the record date, effectively increasing preferred share holdings across all classes and adjusting the company’s capital structure for existing stakeholders.

More about Regen Biopharma

Regen Biopharma, Inc. operates in the biotechnology and biopharmaceutical sector, focusing on the development of therapeutic products, with its capital structure including common stock and multiple series of preferred stock such as Series A, Series AA, Series M, and Series NC.

Average Trading Volume: 1,263,339

Technical Sentiment Signal: Strong Sell

Current Market Cap: $648.3K

Find detailed analytics on RGBP stock on TipRanks’ Stock Analysis page.